Emily Malcolm, PhD, —
Emily holds a Ph.D. in Biochemistry from the University of Iowa and is currently a postdoctoral scholar at the University of Wisconsin-Madison. She graduated with a Masters in Chemistry from the Georgia Institute of Technology and holds a Bachelors in Biology and Chemistry from the University of Central Arkansas.
Emily is passionate about science communication, and, in her free time, writes and illustrates children’s stories.
Articles by Emily Malcolm
Recent Posts
- DPP4 inhibitors for type 2 diabetes found not to raise angioedema risk
- FDA OKs sebetralstat, now Ekterly, as oral on-demand HAE therapy
- ACE inhibitor deemed cause of woman’s intestinal angioedema
- Pendopharm, Kalvista to bring sebetralstat for HAE to Canada
- Voices for change in a village of rare disease advocates, part 3